Nov 20 (Reuters) - Gensight Biologics SA SIGHT.PA :
* GENSIGHT BIOLOGICS ANNOUNCES LAUNCH OF AN OFFERING FOR AN
INDICATIVE AMOUNT OF €5 MILLION THAT HAS RECEIVED SUBSCRIPTION
COMMITMENTS FROM NEW AND EXISTING SHAREHOLDERS TOTALING €4
MILLION
* ISSUE PRICE OF NEW SHARES AT EUR 0.4527 PER SHARE
* CLOSING OF PRIMARY BID OFFERING ON NOVEMBER 20, 2023 AT 10
PM
* OFFERING FOR AN INDICATIVE AMOUNT OF EUR 5 MILLION
Source text for Eikon: ID:nBw3N3RRJa
Further company coverage: SIGHT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))